Eris Lifesciences Associated Pages
Eris Lifesciences FAQs
As of 08-2026, the promoter shareholding in Eris Lifesciences stands at 54.14% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Eris Lifesciences is 5.76% and 0.7% respectively.
The retail shareholding of the Eris Lifesciences is 19.4%.
Changes in shareholding patterns of Eris Lifesciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Eris Lifesciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
